Franco Buzzi

Prospective Randomized Trial of Docetaxel Versus Doxorubicin in Patients With Metastatic Breast Cancer

Stephen Chan, Kay Friedrichs, D. Noel et al. · Journal of Clinical Oncology · 1999 · 638 citations

Medicine, Oncology, Pharmacology +16

Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind study

Giancarlo Agnelli, Gualberto Gussoni, C. Bianchini et al. · The Lancet Oncology · 2009 · 598 citations

Medicine, Oncology, Pharmacology +13

Switching to Anastrozole Versus Continued Tamoxifen Treatment of Early Breast Cancer: Preliminary Results of the Italian Tamoxifen Anastrozole Trial

Francesco Boccardo, A. Rubagotti, Matteo Puntoni et al. · Journal of Clinical Oncology · 2005 · 448 citations

Medicine, Oncology, Pharmacology +17

Letrozole, a new oral aromatase inhibitor: Randomised trial comparing 2.5 mg daily, 0.5 mg daily and aminoglutethimide in postmenopausal women with advanced breast cancer

M. Gershanovich, H.A. Chaudri, H. Lurie et al. · Annals of Oncology · 1998 · 263 citations · Full text

Medicine, Oncology, Pharmacology +15

Treatment of Metastatic Malignant Melanoma with Dacarbazine plus Tamoxifen

Giorgio Cocconi, Mariangela Bella, F. Calabresi et al. · New England Journal of Medicine · 1992 · 239 citations · Full text

Medicine, Oncology, Pharmacology +11